Ascalon International

Ascalon International is an oncology drug development company that creates and manages a portfolio of oncology drugs.

Ascalon International, Inc., an oncology drug development company, creates and manages a portfolio of oncology drugs. The company also conducts biomarker-based clinical trials in oncology. In addition, it focuses on developing products by clinical development and regulatory execution, either by establishment of a joint development with the product owner or by acquisition of the product. The company has a strategic and operational alliance with Parexel. Ascalon International, Inc. was founded in 2009 and is based in Scottsdale, Arizona.